Tucker Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.94K Sell
28
-452
-94% -$97.4K ﹤0.01% 361
2026
Q1
$96.4K Buy
480
+63
+15% +$13K 0.03% 185
2025
Q4
$86.1K Buy
417
+142
+52% +$28.4K 0.03% 220
2025
Q3
$49.3K Sell
275
-14
-5% -$2.38K 0.01% 181
2025
Q2
$46.6K Buy
289
+213
+280% +$33.9K 0.01% 167
2025
Q1
$12.9K Buy
76
+34
+81% +$5.91K ﹤0.01% 220
2024
Q4
$6.98K Buy
+42
New +$7.18K ﹤0.01% 884
2021
Q3
Sell
-3
Closed -$518 385
2021
Q2
$518 Sell
3
-2
-40% -$330 ﹤0.01% 338
2021
Q1
$803 Hold
5
﹤0.01% 316
2020
Q4
$840 Buy
+5
New +$811 ﹤0.01% 342

Other funds holding FBT

Tucker Asset Management's FBT Position: Q2 2026 in Review

Tucker Asset Management reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 94% in Q2 2026, selling an estimated $97.4K and leaving 28 shares worth $6.94K. The position accounts for ﹤0.01% of the portfolio, ranked #361.

Tucker Asset Management first reported a position in FBT in Q4 2020 and has held it in 10 quarters since. The position peaked at $96.4K in Q1 2026. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Tucker Asset Management held 28 shares of First Trust NYSE Arca Biotechnology Index Fund worth $6.94K as of Q2 2026.
  • Tucker Asset Management sold 452 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $97.4K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Tucker Asset Management's portfolio in Q2 2026, its #361 holding.
  • Tucker Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2020 and has held it in 10 quarters since.
  • Tucker Asset Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $96.4K in Q1 2026.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Tucker Asset Management's 13F filing for Q2 2026, filed 27 Aug 2026.